DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 113 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $24,682,000 | +16.6% | 1,120,359 | -4.8% | 0.15% | -46.8% |
Q3 2020 | $21,165,000 | -25.6% | 1,176,513 | +5.0% | 0.28% | +28.8% |
Q2 2020 | $28,457,000 | -99.9% | 1,120,359 | 0.0% | 0.22% | +15.3% |
Q1 2020 | $19,415,821,000 | -21.3% | 1,120,359 | 0.0% | 0.19% | +15.2% |
Q4 2019 | $24,681,509,000 | +153315.6% | 1,120,359 | 0.0% | 0.16% | +47.3% |
Q3 2019 | $16,088,000 | – | 1,120,359 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |